期刊
CRITICAL REVIEWS IN BIOTECHNOLOGY
卷 42, 期 4, 页码 532-547出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/07388551.2021.1951649
关键词
Mycobacterium tuberculosis; systems biology; bioinformatics; proteomics; genomics; genetic engineering
资金
- National Institutes of Health [R01-AI132711, R01-AI149852]
Tuberculosis is a prevalent global disease, and current vaccines are not sufficient in protection. Despite many vaccines being evaluated in clinical trials, none have proven significantly successful yet. Therefore, new strategies are urgently needed to design more effective TB vaccines, and the emergence of new technologies will accelerate this process.
Tuberculosis (TB) is one of the most prevalent diseases worldwide. The currently available Bacillus Calmette-Guerin vaccine is not sufficient in protecting against pulmonary TB. Although many vaccines have been evaluated in clinical trials, but none of them yet has proven to be more successful. Thus, new strategies are urgently needed to design more effective TB vaccines. The emergence of new technologies will undoubtedly accelerate the process of vaccine development. This review summarizes the potential and validated applications of emerging technologies, including: systems biology (genomics, proteomics, and transcriptomics), genetic engineering, and other computational tools to discover and develop novel vaccines against TB. It also discussed that the significant implementation of these approaches will play crucial roles in the development of novel vaccines to cure and control TB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据